Institutional investors purchased a net $1.2 million shares of OPK during the quarter ended December 2017. This may signal that the smart money is gaining interest in this company as the 23.73% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SSGA FUNDS MANAGEMENT, INC. Bought 1.5 Million shares of OPKO Health Inc
INVESCO POWERSHARES CAPITAL MANA... Bought 1.3 Million shares of OPKO Health Inc
MCMORGAN & CO. LLC Bought 606.4 Thousand shares of OPKO Health Inc